Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 136 articles:
HTML format



Single Articles


    January 2024
  1. ZHU Z
    Early-life airway microbiome and childhood asthma development.
    Eur Respir J. 2024;63:2302187.
    PubMed    


  2. HOGMAN M, Bowerman C, Chavez L, Dressel H, et al
    ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (F (ENO(50)) ).
    Eur Respir J. 2024;63:2300370.
    PubMed     Abstract available



  3. ERJ Podcast January 2024: The microbiome in early life and childhood asthma.
    Eur Respir J. 2024;63:24E6301.
    PubMed    


    December 2023
  4. SUNDE RB MD PHD, Thorsen J MD PhD, Kim M MSc PhD, Schoos AM MD PhD, et al
    Bacterial Colonization of the Airway in Neonates and Risk of Asthma and Allergy Until Age 18 Years.
    Eur Respir J. 2023 Dec 14:2300471. doi: 10.1183/13993003.00471-2023.
    PubMed     Abstract available


  5. BEASLEY R, Noble J, Weatherall M
    Clinical remission with biologic therapies in severe asthma: a matter of definition.
    Eur Respir J. 2023;62:2301844.
    PubMed    


  6. WECKMANN M, Reddy KD
    Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow.
    Eur Respir J. 2023;62:2301552.
    PubMed    


    November 2023
  7. CIVIDINI S, Sinha I, Donegan S, Maden M, et al
    Best step-up treatments for children with uncontrolled asthma: A systematic review and network meta-analysis of individual participant data.
    Eur Respir J. 2023 Nov 9:2301011. doi: 10.1183/13993003.01011-2023.
    PubMed     Abstract available


  8. VALENCIA-HERNANDEZ CA, Del Greco M F, Sundaram V, Portas L, et al
    Asthma and incident coronary heart disease: an observational and Mendelian randomisation study.
    Eur Respir J. 2023 Nov 9:2301788. doi: 10.1183/13993003.01788-2023.
    PubMed     Abstract available


  9. SORIANO JB, Polverino F
    Sex and gender in COPD and asthma.
    Eur Respir J. 2023;62:2301505.
    PubMed    


  10. MORGAN C, Higbee D
    An attack of asthma is not an attack of the heart: clarifying causal links between asthma and incident coronary heart disease.
    Eur Respir J. 2023;62:2302009.
    PubMed    


    October 2023
  11. MCDOWELL PJ, McDowell R, Busby J, Eastwood MC, et al
    Clinical remission in severe asthma with Biologic Therapy: an analysis from the UK Severe Asthma Registry.
    Eur Respir J. 2023 Oct 19:2300819. doi: 10.1183/13993003.00819-2023.
    PubMed     Abstract available


  12. HERRERA-LUIS E, de la Rosa-Baez C, Huntsman S, Eng C, et al
    Novel insights into the whole blood DNA methylome of asthma in ethnically diverse children and youth.
    Eur Respir J. 2023 Oct 6:2300714. doi: 10.1183/13993003.00714-2023.
    PubMed     Abstract available



  13. October Podcast: ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma.
    Eur Respir J. 2023;62:23E6204.
    PubMed    


    September 2023
  14. FIOCCHI AG, Phipatanakul W, Zeiger RS, Durrani SR, et al
    Dupilumab leads to better-controlled asthma & quality of life in children: the VOYAGE study.
    Eur Respir J. 2023 Sep 21:2300558. doi: 10.1183/13993003.00558-2023.
    PubMed     Abstract available


  15. PAPI A, Ferreira DS, Agache I, Baraldi E, et al
    European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma.
    Eur Respir J. 2023 Sep 7:2300047. doi: 10.1183/13993003.00047-2023.
    PubMed     Abstract available


  16. FARINHA I, Heaney LG
    Defining trajectory in severe asthma: can it be changed?
    Eur Respir J. 2023;62:2301281.
    PubMed    


    August 2023
  17. VON BULOW A, Hansen S, Sandin P, Ernstsson O, et al
    Severe asthma trajectories in adults: findings from the NORDSTAR cohort.
    Eur Respir J. 2023 Aug 24:2202474. doi: 10.1183/13993003.02474-2022.
    PubMed     Abstract available


  18. POWELL WT, Reeves SR
    From small to big, using microRNA profiling to investigate infant origins of childhood asthma.
    Eur Respir J. 2023;62:2301052.
    PubMed    


  19. OSADNIK CR, Brighton LJ, Burtin C, Cesari M, et al
    European Respiratory Society statement on frailty in adults with chronic lung disease.
    Eur Respir J. 2023;62:2300442.
    PubMed     Abstract available


    July 2023
  20. CAZZOLA M, Page CP, Matera MG, Rogliani P, et al
    Revisiting Asthma Pharmacotherapy: Where Do We Stand and Where Do We Want to Go?
    Eur Respir J. 2023 Jul 20:2300700. doi: 10.1183/13993003.00700-2023.
    PubMed     Abstract available


  21. NANZER AM, Taylor V, Hearn AP, Kavanagh JE, et al
    The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
    Eur Respir J. 2023 Jul 20:2300245. doi: 10.1183/13993003.00245-2023.
    PubMed    


    June 2023
  22. ZHU Z, Freishtat RJ, Harmon B, Hahn A, et al
    Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study.
    Eur Respir J. 2023 Jun 15:2300502. doi: 10.1183/13993003.00502-2023.
    PubMed     Abstract available


  23. DUIJTS L
    Prematurity-related chronic respiratory disease across the life course.
    Eur Respir J. 2023;61:2300662.
    PubMed    


  24. VAN DER VEER T, de Koning Gans JM, Braunstahl GJ, Pieters A, et al
    The effect of beclomethasone-formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis: the FORZA randomised-controlled trial.
    Eur Respir J. 2023 Jun 1:2300186. doi: 10.1183/13993003.00186-2023.
    PubMed    


    April 2023
  25. EIWEGGER T, Bendien SA
    Defining the questions to be asked in severe asthma trials: data from the COMSA working group.
    Eur Respir J. 2023;61:2202058.
    PubMed    


    March 2023
  26. PULAKKA A, Risnes K, Metsala J, Alenius S, et al
    Preterm birth and asthma and COPD in adulthood: a nationwide register study from two Nordic countries.
    Eur Respir J. 2023 Mar 29:2201763. doi: 10.1183/13993003.01763-2022.
    PubMed     Abstract available


  27. MAHMOUD O, Granell R, Peralta GP, Garcia-Aymerich J, et al
    Early-life and health behaviour influences on lung function in early adulthood.
    Eur Respir J. 2023;61:2001316.
    PubMed     Abstract available


  28. CHARRIOT J, Ahmed E, Bourdin A
    Local targeting of TSLP: feat or defeat.
    Eur Respir J. 2023;61:2202389.
    PubMed    


  29. SCHNEIDER S, Poglitsch K, Morgenstern C, Quint T, et al
    Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
    Eur Respir J. 2023;61:2201335.
    PubMed     Abstract available


  30. NOBLE PB, Donovan GM
    If your patient with asthma wheezes when sitting or lying quietly, lung function testing may reveal small airway disease.
    Eur Respir J. 2023;61:2202307.
    PubMed    


  31. CORREN J, Brightling CE, Boulet LP, Porsbjerg C, et al
    Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.
    Eur Respir J. 2023;61:2202202.
    PubMed    


  32. BOULET LP, Boulay ME, Cote A, FitzGerald JM, et al
    Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry.
    Eur Respir J. 2023;61:2201194.
    PubMed     Abstract available


    February 2023
  33. GAUVREAU GM, Hohlfeld JM, FitzGerald MJ, Boulet LP, et al
    Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Eur Respir J. 2023 Feb 23:2201193. doi: 10.1183/13993003.01193-2022.
    PubMed     Abstract available


  34. ABDO M, Kirsten AM, von Mutius E, Kopp M, et al
    Minimal Clinically Important Difference for Impulse Oscillometry in Adults with Asthma.
    Eur Respir J. 2023 Feb 9:2201793. doi: 10.1183/13993003.01793-2022.
    PubMed     Abstract available


  35. SAVOURE M, Bousquet J, Leynaert B, Renuy A, et al
    Rhinitis phenotypes and multimorbidities in the general population: the CONSTANCES cohort.
    Eur Respir J. 2023;61:2200943.
    PubMed     Abstract available


    January 2023
  36. POLLOCK J, Chalmers JD
    Aspergillus sensitisation: an underappreciated treatable trait in airway disease.
    Eur Respir J. 2023;61:2202042.
    PubMed    


  37. FAWCETT KA
    Seeing the trees for the wood: reducing heterogeneity in genomic studies of asthma.
    Eur Respir J. 2023;61:2201931.
    PubMed    


    December 2022
  38. DAVIES D, Hyland ME, Lanario JW, Jones RC, et al
    Moving towards patient-centred outcomes: the Severe Asthma Questionnaire.
    Eur Respir J. 2022 Dec 30:2202305. doi: 10.1183/13993003.02305-2022.
    PubMed    


  39. RATTU A, Khaleva E, Brightling C, Dahlen SE, et al
    Identifying and appraising outcome measures for severe asthma: a systematic review.
    Eur Respir J. 2022 Dec 22:2201231. doi: 10.1183/13993003.01231-2022.
    PubMed     Abstract available


  40. KOCKS J, van der Molen T, Voorham J, Baldi S, et al
    Development of a tool to detect small airways dysfunction in asthma clinical practice.
    Eur Respir J. 2022 Dec 14:2200558. doi: 10.1183/13993003.00558-2022.
    PubMed     Abstract available


  41. HAHN DL, Webley W
    U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2200571.
    PubMed    


  42. SPARREMAN MIKUS M, Kolmert J, Andersson LI, Dahlen SE, et al
    Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2201795.
    PubMed    


  43. MENZIES-GOW A, Gurnell M, Heaney LG, Corren J, et al
    Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
    Eur Respir J. 2022;60:2103226.
    PubMed     Abstract available


    November 2022
  44. CHERIAN M, Magner KMA, Whitmore GA, Vandemheen KL, et al
    Patient and physician factors associated with symptomatic undiagnosed asthma or COPD.
    Eur Respir J. 2022 Nov 3. pii: 13993003.01721-2022.
    PubMed     Abstract available


  45. BUSSE WW
    Improving systemic corticosteroid stewardship in asthma.
    Eur Respir J. 2022;60.
    PubMed    


  46. PARK JS, Cho YJ, Yun JY, Lee HJ, et al
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


  47. PETSKY H
    Randomised controlled trials utilising F ENO to manage asthma: is it time to acknowledge that "one size does not fit all"?
    Eur Respir J. 2022;60.
    PubMed    


  48. ROBERTS G
    Is it time to consider allergen immunotherapy earlier in the management of allergic asthma?
    Eur Respir J. 2022;60.
    PubMed    


    October 2022
  49. KHALEVA E, Rattu A, Brightling C, Bush A, et al
    Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
    Eur Respir J. 2022 Oct 13. pii: 13993003.00606-2022.
    PubMed     Abstract available


  50. POLVERINO F, Marin JM
    The lower respiratory tract: the hot spot for chronic fixed airflow limitation.
    Eur Respir J. 2022;60.
    PubMed    


    September 2022
  51. PERSSON C
    Creola bodies and pathogenesis of childhood asthma.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01204-2022.
    PubMed    


  52. COLEMAN C, Khaleva E, Rattu A, Frankemolle B, et al
    Narrative Review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00837-2022.
    PubMed     Abstract available


  53. LIU J, Bowatte G, Pham J, Perret JL, et al
    Pre-pubertal smoke exposure of fathers and increased risk of offspring asthma: a possible transgenerational effect.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00257-2022.
    PubMed    


  54. SORIANO JB
    Planetary respiratory health for asthma, rhinoconjunctivitis and eczema.
    Eur Respir J. 2022;60.
    PubMed    


  55. CHAN JSK, Murray RB, Price D
    Oral corticosteroids in asthma and beyond: moving forward.
    Eur Respir J. 2022;60.
    PubMed    


  56. PERREM L, Subbarao P
    Moving the dial on identifying endotypes of asthma from early life.
    Eur Respir J. 2022;60.
    PubMed    



  57. "Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma." M.K. Ali, R.Y. Kim, A.C. Brown et al. Eur Respir J 2020; 55: 1901340.
    Eur Respir J. 2022;60.
    PubMed    


  58. PAVORD ID
    Case-finding and diagnosis of obstructive airway diseases: the Dragons' Den experience.
    Eur Respir J. 2022;60.
    PubMed    


    August 2022
  59. CHAN R, Lipworth B
    Interactions between spirometry and oscillometry in patients with moderate to severe asthma.
    Eur Respir J. 2022 Aug 18. pii: 13993003.00543-2022.
    PubMed    


  60. LEE S, Prokopenko D, Kelly RS, Lutz S, et al
    Zinc finger protein 33B demonstrates sex-interaction with atopy-related markers in childhood asthma.
    Eur Respir J. 2022 Aug 11. pii: 13993003.00479-2022.
    PubMed     Abstract available


    July 2022
  61. PERRET JL, Dharmage SC, Bui DS
    Early life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
    Eur Respir J. 2022 Jul 26. pii: 13993003.01141-2022.
    PubMed    


  62. MCLOUGHLIN RF, Clark VL, Urroz PD, Gibson PG, et al
    Increasing physical activity in severe asthma: a systematic review and meta-analysis.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00546-2022.
    PubMed     Abstract available


  63. VAN MEEL ER, Duijts L
    Reply to: "Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?"
    Eur Respir J. 2022 Jul 26. pii: 13993003.01384-2022.
    PubMed    


  64. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    PubMed     Abstract available


  65. REDMOND C, Heaney LG, Chaudhuri R, Jackson DJ, et al
    Benefits of specialist severe asthma management: demographic and geographic disparities.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00660-2022.
    PubMed     Abstract available


  66. HOLMES J, McGarvey LP, Birring SS, Fletcher H, et al
    An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
    Eur Respir J. 2022 Jul 1. pii: 13993003.03205-2021.
    PubMed     Abstract available


  67. SALTER B, Zhao N, Son K, Suray Tan N, et al
    Airway autoantibodies are determinants of asthma severity.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00442-2022.
    PubMed     Abstract available


  68. WURZEL D, Licciardi PV
    Targeted strategies are needed to prevent childhood asthma.
    Eur Respir J. 2022;60.
    PubMed    


  69. WARK PAB
    We need to understand why viral infections lead to acute asthma.
    Eur Respir J. 2022;60.
    PubMed    


  70. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
    Eur Respir J. 2022;60.
    PubMed    


  71. COUILLARD S
    The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence.
    Eur Respir J. 2022;60.
    PubMed    


    June 2022

  72. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343-373.
    Eur Respir J. 2022;59.
    PubMed    


  73. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


  74. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


    May 2022
  75. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed     Abstract available


  76. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed     Abstract available


  77. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    PubMed     Abstract available


  78. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    PubMed     Abstract available


  79. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    PubMed     Abstract available


  80. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    April 2022
  81. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    PubMed    


  82. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    PubMed     Abstract available


  83. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  84. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    March 2022
  85. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    PubMed     Abstract available


  86. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    PubMed     Abstract available


  87. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    PubMed     Abstract available


  88. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    PubMed    


  89. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
    Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
    PubMed     Abstract available


  90. VONK JM, Roukema J
    Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
    Eur Respir J. 2022;59.
    PubMed    


  91. THAMRIN C, Robinson PD, Farah CS, King GG, et al
    Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
    Eur Respir J. 2022;59.
    PubMed    


  92. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
    Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    February 2022
  93. MAISON N, Omony J, Illi S, Thiele D, et al
    T-high asthma phenotypes across life span.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
    PubMed     Abstract available


  94. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
    Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
    PubMed     Abstract available


  95. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
    Asthma management in low- and middle-income countries: case for change.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
    PubMed     Abstract available


  96. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
    The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
    PubMed     Abstract available


  97. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
    Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
    PubMed     Abstract available


  98. LOUIS R, Satia I, Ojanguren I, Schleich F, et al
    European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.
    Eur Respir J. 2022 Feb 15. pii: 13993003.01585-2021.
    PubMed     Abstract available


  99. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
    Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
    PubMed     Abstract available


  100. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
    The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
    PubMed     Abstract available


  101. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    PubMed    


  102. MARCON A, Locatelli F, Accordini S
    The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
    Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
    PubMed    


  103. KEARNS N, Bruce P, Williams M, Doppen M, et al
    Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.
    Eur Respir J. 2022 Feb 3. pii: 13993003.02309-2021.
    PubMed     Abstract available


  104. SEYS SF, Long MB
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
    Eur Respir J. 2022;59.
    PubMed    


    January 2022
  105. PARASKAKIS E, Sarikloglou E, Fouzas S, Steiropoulos P, et al
    Improved prediction of asthma exacerbations by measuring distal airway inflammation.
    Eur Respir J. 2022 Jan 27. pii: 13993003.01684-2021.
    PubMed    


  106. GAUVREAU GM, Davis BE, Scadding G, Boulet LP, et al
    Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience.
    Eur Respir J. 2022 Jan 27. pii: 13993003.02782-2021.
    PubMed     Abstract available


  107. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
    Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
    Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
    PubMed     Abstract available


  108. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
    Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
    Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
    PubMed     Abstract available


  109. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
    Vulnerability to acid reflux of the airway epithelium in severe asthma.
    Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
    PubMed     Abstract available


  110. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
    Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
    Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
    PubMed     Abstract available


  111. BENSON VS, Hartl S, Barnes N, Galwey N, et al
    Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    December 2021
  112. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
    Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
    PubMed     Abstract available


  113. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
    Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
    PubMed     Abstract available


  114. AGARWAL R, Muthu V
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
    PubMed    


  115. HAVETTE A, Regard L, Roche N, Burgel PR, et al
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
    PubMed    


  116. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
    Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
    Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
    PubMed     Abstract available


  117. GURDENIZ G, Ernst M, Rago D, Kim M, et al
    Neonatal metabolome of cesarean section and risk of childhood asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
    PubMed     Abstract available


  118. RYAN D, Sabroe I
    Identifying and addressing health inequalities in asthma care.
    Eur Respir J. 2021;58.
    PubMed    


  119. PAPAIOANNOU AI, Photiades A, Gaga M
    Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
    Eur Respir J. 2021;58.
    PubMed    


  120. PARK S, Lee S, Kim Y, Cho S, et al
    Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    November 2021
  121. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    PubMed    


  122. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    PubMed     Abstract available


  123. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    PubMed     Abstract available


  124. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  125. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    PubMed    


    October 2021
  126. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed     Abstract available


  127. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed     Abstract available


  128. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    PubMed     Abstract available


  129. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    PubMed    


  130. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    PubMed     Abstract available


  131. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  132. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    PubMed     Abstract available


  133. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    PubMed     Abstract available


  134. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    PubMed     Abstract available


  135. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    PubMed    


    April 2021
  136. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.